Binding sites for a peripheral type benzodiazepine antagonist ([3H] PK 11195) in human iris
- 1 June 1987
- journal article
- research article
- Published by Elsevier in Neuropharmacology
- Vol. 26 (6) , 549-552
- https://doi.org/10.1016/0028-3908(87)90146-8
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Decreased peripheral benzodiazepine binding sites in platelets of neuroleptic-treated schizophrenicsEuropean Journal of Pharmacology, 1986
- Characterization of peripheral benzodiazepine binding sites in human term placentaBiochemical Pharmacology, 1986
- Characterization of solubilized “peripheral type” benzodiazepine binding sites from rat adrenals by using [3H]PK 11195, an isoquinoline carboxamide derivativeBiochemical Pharmacology, 1985
- Characterization of peripheral type benzodiazepine binding sites in human and rat platelets by using [3H]PK 11195. Studies in hypertensive patientsBiochemical Pharmacology, 1984
- Autoradiographic localization of peripheral benzodiazepine binding sites in the cat brain with [3H]PK 11195Brain Research Bulletin, 1984
- In vivo labelling in several rat tissues of ‘peripheral type’ benzodiazepine binding sitesEuropean Journal of Pharmacology, 1984
- Peripheral and central-type benzodiazepine binding sites in mammalian ocular tissuesExperimental Eye Research, 1984
- Differentiation between two ligands for peripheral benzodiazepine binding sites, [3H]R05-4864 and [3H]PK 11195, by thermodynamic studiesLife Sciences, 1983
- Labelling of “Peripheral‐Type” Benzodiazepine Binding Sites in the Rat Brain By Using [3H]PK 11195, an Isoquinoline Carboxamide Derivative: Kinetic Studies and Autoradiographic LocalizationJournal of Neurochemistry, 1983
- Peripheral benzodiazepine binding sites: Effect of PK 11195, 1-(2-chlorophenyl)-n-methyl-n-(1-methylpropyl)-3-isoquinolinecarboxamideLife Sciences, 1983